Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes
|ClinicalTrials.gov Identifier: NCT01350674|
Recruitment Status : Suspended
First Posted : May 10, 2011
Last Update Posted : October 16, 2017
This is an observational prospective study. Role of EBUS-TBNA (endobronchial ultrasound transbronchial needle aspiration) is evaluated to diagnose tuberculosis in mediastinal and/or hilar lymph nodes.
The investigators analyse the specificity and sensibility of this technique to diagnose tuberculosis in mediastinal and/or hilar lymph nodes.
Patients with mediastinal and/or hilar lymph nodes on X-ray or CT thorax where a tuberculosis is the most probable cause and who have no parenchymal lesions suspected for tuberculosis and without other lymph nodes that are more easily accessible or palpable will be included in this study.
|Condition or disease||Intervention/treatment|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Role of EBUS-TBNA (Endobronchial Ultrasound Transbronchial Needle Aspiration- in Diagnosing Tuberculosis in Mediastinal and/or Hilar Lymph Nodes|
|Study Start Date :||December 2010|
|Estimated Primary Completion Date :||December 2017|
|Estimated Study Completion Date :||March 2018|
patients undergoing EBUS
endobronchial ultrasound transbronchial needle aspiration
- The ratio of tuberculosis in mediastinal lymph nodes [ Time Frame: 8 weeks ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01350674
|CHU St. Pierre; pulmonology department|
|Brussels, Belgium, 1000|
|Principal Investigator:||Inge M Muylle, MD||CHU St. Pierre Brussels|